PHK
KURA icon

Point72 Hong Kong’s Kura Oncology KURA Stock Holding History

Point72 Hong Kong’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,754
Closed -$215K – 930
2022
Q3 		$215K Buy
+15,754
New +$243K 0.01% 1026
2022
Q2 		– Sell
-2,927
Closed -$47K – 2187
2022
Q1 		$47K Sell
2,927
-933
-24% -$13.5K ﹤0.01% 1349
2021
Q4 		$54K Buy
3,860
+710
+23% +$11.5K ﹤0.01% 1321
2021
Q3 		$59K Sell
3,150
-242
-7% -$4.56K ﹤0.01% 1483
2021
Q2 		$71K Buy
+3,392
New +$84.2K ﹤0.01% 1396
2021
Q1 		– Sell
-2,747
Closed -$90K – 2029
2020
Q4 		$90K Buy
+2,747
New +$96.5K ﹤0.01% 1090
2020
Q1 		– Sell
-503
Closed -$7K – 1160
2019
Q4 		$7K Buy
+503
New +$7.45K ﹤0.01% 1018
2019
Q3 		– Sell
-1,281
Closed -$25K – 1193
2019
Q2 		$25K Buy
+1,281
New +$21.3K 0.01% 743
2018
Q4 		– Sell
-96
Closed -$2K – 1062
2018
Q3 		$2K Sell
96
-1,724
-95% -$33.1K ﹤0.01% 776
2018
Q2 		$33K Buy
+1,820
New +$30.8K 0.01% 506

Other funds holding KURA

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Point72 Hong Kong's KURA Position: Q4 2022 in Review

Point72 Hong Kong sold out of Kura Oncology (KURA) in Q4 2022, closing a stake of 15,754 shares — an estimated $215K sold.

Point72 Hong Kong first reported a position in KURA in Q2 2018 and held it in 10 quarters. The position peaked at $215K in Q3 2022. 142 funds tracked by Wall St. Rank hold KURA as of Q4 2022.

  • Point72 Hong Kong reported no remaining Kura Oncology position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 15,754 Kura Oncology shares in Q4 2022, an estimated $215K.
  • Point72 Hong Kong first reported a position in Kura Oncology in Q2 2018 and held it in 10 quarters.
  • Point72 Hong Kong's Kura Oncology position peaked at $215K in Q3 2022.
  • 142 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.